Strain Analysis as a Right Ventricle Contractility Marker
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Faktiske)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Lyon, Frankrike, 69004
- Hôpital de La Croix Rousse
-
Lyon, Frankrike, 69007
- Hôpital Saint Joseph Saint Luc
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Male or female ≥ 18 years
- Patients with renal failure treated with intermittent hemodialysis
- Patients who received an information and did not opposed to participate in the study, or, if unconscious patient at the time of inclusion: a person of trust as defined in Article L. 1111-6 of the Public Health Code, failing that, the family or, failing that, a person maintaining stable link, having received information and not opposed to participate in the study.
Exclusion Criteria:
- Patients with heart disease (valvular, ischemic, rhythmic)
- Patients with ejection fraction of left ventricular altered <45%
- Chronic dialysis patients
Patients referred in Articles L. 1121-5, L.1121-6, L.1121-7, L.1121-8 of the Public Health Code:
- Pregnant women, parturients or nursing mothers
- Persons deprived of their liberty by a judicial or administrative decision, persons subject to psychiatric care, persons admitted to a health or social institution for purposes other than research
- Minor Patients
- Major persons who are subject to a legal protection measure or are unable to express their consent
- Patients not willing to participate in the study
- Patients not affiliated to a social security
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Diagnostisk
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Annen: ultrasound measurements
ultrasound measurements of myocardial deformation of free wall right ventricle during a sharp decline of right ventricle preload induced during a session of Intermittent hemodialysis.
|
ultrasound measurements of myocardial deformation of free wall right ventricle at 4 time points during a session of intermittent hemodialysis : before the intermittent hemodialysis connection, just after starting hemodialysis, after 1 hour of hemodialysis and 5 minutes before restitution
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Evaluation of the change in the Longitudinal strain of the free wall right ventricle
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Evaluation of the change in S' right ventricle wave
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
Evaluation of the change in tricuspid annular plane systolic excursion (TAPSE)
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
Evaluation of the change in visual left ventricular ejection fraction (LVEF)
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
Evaluation of the change in mitral E wave
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
Evaluation of the change in mitral A wave
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
Evaluation of the change in wave E ' at the lateral mitral ring
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
Evaluation of the change in systolic fraction of pulmonary venous flow
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
inter individual variability of Longitudinal strain of the free wall right ventricle
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
Each measurement will be performed by two blind operators
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
|
intra individual variability of Longitudinal strain of the free wall right ventricle
Tidsramme: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
Each measurement will be performed by two blind operators
|
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Zoé Schmitt, Hôpital de la Croix-Rousse
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Faktiske)
Primær fullføring
Studiet fullført (Faktiske)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 69HCL16-0370
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .